9/25/2007

The FDA is considering an additional approval for the chronic constipation drug Amitiza as a treatment for irritable bowel syndrome with constipation in an 8-microgram dose. The agency is expected to issue a decision in the second quarter of 2008.

Full Story:
CNNMoney

Related Summaries